Imageens, had the privilege of participating in Medica 2021, where we unveiled our state-of-the-art solution, CardioInspect . This revolutionary technology is positioned to revolutionize cardiovascular risk assessment by offering predictive insights that extend up to 8.5 years into the future.
This innovation is rooted in vascular aging biomarkers, quantified through a certified and clinical validated technology . It delivers a predictive score and boasts clinical validation across several significant cohorts (+77 publications). Among these is the Multi-Ethnic Study of Atherosclerosis (MESA), spearheaded by Johns Hopkins, which tracked 3,675 patients over an 8.5-year period.
Cardiovascular diseases remain a global health challenge, affecting millions of lives and placing a significant burden on healthcare systems worldwide. With CardioInspect, Imageens aims to confront this challenge head-on by introducing a solution that offers unparalleled accuracy in forecasting a patient’s cardiovascular risk.
During the event, Jean-Yves Yan, Senior Software Engineer at Imageens, shared his expertise and highlighted the transformative capabilities of CardioInspect.
“Consider a 35-year-old patient with an unfavorable lifestyle and specific risk factors. Our advanced technology can analyze the rigidity of their aorta and the efficiency of cardiac wall contractions. Surprisingly, this patient’s cardiovascular age might resemble that of an 85-year-old individual. The encouraging news is that with appropriate interventions and lifestyle adjustments, the patient can experience a significant reduction in their vascular age over time.” — Yan explained.
By harnessing the potential of medical imaging and predictive algorithms, this innovative solution empowers both patients and healthcare providers with invaluable insights to develop more effective preventive care strategies.
Imageens, a pioneering French Healthtech startup, is proud to announce its participation in MEDICA 2021, the leading international trade fair for the medical industry. From 15 to 18 November 2021, Imageens will exhibit its innovative technologies and demonstrate its commitment to revolutionizing medical imaging for improved patient care and diagnostics.
MEDICA is widely recognized as the world’s largest event for the medical sector, attracting thousands of professionals and industry leaders from around the globe. As a prominent participant, Imageens aims to leverage this prestigious platform to showcase its state-of-the-art imaging solutions, designed to address the evolving needs of healthcare providers and patients.
“We are excited to be part of MEDICA 2021 and share our latest innovations with the global medical community, solidifying our position as a frontrunner in the field of medical imaging.” said TED Baldwin , CEO at Imageens.
“MEDICA offers an unparalleled platform for networking and collaboration within the medical industry, making it an ideal venue for Imageens to foster valuable connections with potential partners, distributors, and healthcare professionals.” — the CEO added.